| Literature DB >> 27776725 |
Menfil A Orellana-Barrios1, Drew Payne2, Rita M Medrano-Juarez2, Shengping Yang2, Kenneth Nugent2.
Abstract
The use of electronic cigarettes (e-cigarettes) is increasing, but their use as a smoking-cessation aid is controversial. The reporting of e-cigarette studies on cessation is variable and inconsistent. To date, only 1 randomized clinical trial has included an arm with other cessation methods (nicotine patches). The cessation rates for available clinical trials are difficult to compare given differing follow-up periods and broad ranges (4% at 12 months with non-nicotine e-cigarettes to 68% at 4 weeks with concomitant nicotine e-cigarettes and other cessation methods). The average combined abstinence rate for included prospective studies was 29.1% (combination of 6-18 months׳ rates). There are few comparable clinical trials and prospective studies related to e-cigarettes use for smoking cessation, despite an increasing number of citations. Larger randomized clinical trials are essential to determine whether e-cigarettes are effective smoking-cessation devices.Entities:
Keywords: Electronic cigarettes; Electronic nicotine delivery devices; Smoking cessation; Tobacco harm reduction
Mesh:
Year: 2016 PMID: 27776725 DOI: 10.1016/j.amjms.2016.07.013
Source DB: PubMed Journal: Am J Med Sci ISSN: 0002-9629 Impact factor: 2.378